Elevated lipoprotein(a)
1 paper
Trial sponsors
Company2 trialsPhase 2304 people
Funding
1 grant since 2023National Heart, Lung, and Blood InstituteUS$506.7k
Latest
33 in 12 monthsCurrent Atherosclerosis Reports
RNA-Based Therapies for Lipoprotein(a) Reduction: Antisense Oligonucleotides, Small Interfering RNAs, and Emerging Platforms
ReviewInterventions
Journal of Clinical Lipidology
Real-world threshold-based eligibility for emerging lipoprotein(a)-targeted therapies in chronic and acute coronary syndrome
Cohort study of 5,942 peopleLipoprotein
JACC Advances
Lipoprotein(a) in Disaggregated South Asian Groups: An Analysis of MASALA and the UK Biobank
Cohort study of 6,845 peoplePopulations
JACC Asia
Elevated Lipoprotein(a) in Asian Populations and its Implications for Cardiovascular Disease
Systematic review of observational studiesLipoprotein
Frontiers in Cardiovascular Medicine
Lp(a), platelet count, aspirin and cardiovascular outcome: a prospective cohort analysis
Cohort study of 250,927 peoplePlatelet count
International Journal of Molecular Sciences
Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic Syndrome
Biomedicines
Associations of Elevated Lipoprotein(a) with C-Reactive Protein and Type 2 Diabetes in a Multiethnic Population
Cross-sectional study of 2,083 peopleType 2 diabetes